Concepedia

Gregory M. Coté

GM

92

Publications

5.6K

Citations

42

H-Index

1999

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

Gregory M. Coté is an author at Massachusetts General Hospital specializing in medicine, tumor biology, and pathology.

ORCID

Top concepts

Publications per year

1999–2024

92

Publications

92

Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study

Mrinal M. Gounder, Patrick Schöffski, Robin L. Jones et al. · The Lancet Oncology · 2020 · 383 citations

, , +8

Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma

Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat et al. · Journal of Clinical Oncology · 2020 · 285 citations · Full text

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Ingo K. Mellinghoff, Marta Peñas-Prado, Katherine B. Peters et al. · Clinical Cancer Research · 2021 · 234 citations · Full text

Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors

Mrinal M. Gounder, Ravin Ratan, Thierry Alcindor et al. · New England Journal of Medicine · 2023 · 213 citations · Full text

Programmed Cell Death Ligand 1 Expression in Osteosarcoma

Jacson Shen, Gregory M. Coté, Edwin Choy et al. · Cancer Immunology Research · 2014 · 196 citations · Full text

, , +15

Rows per page

1–5 of 92